• KAVL recently acquired patent, announced creation of wholly owned subsidiary to develop smoking cessation products.
• Company plans to create products that satisfy smokers but are free from nicotine’s addictive traits.
• CEO says company is excited to help “all nicotine users lead healthier and higher-quality lives.”

The Centers for Disease Control and Prevention report that smoking is the leading cause of preventable death in the world today (https://ibn.fm/dxZ1W). With the help of new and innovative cessation products, the  7 million deaths that occur every year due to smoking could be prevented — and Kaival Brands Innovations Group (OTCQB: KAVL) is determined to do all it can to make it happen.

A company focused on growing and incubating innovative and profitable products into mature, dominant brands, Kaival Brands has turned its attention to the smoking cessation space (https://ibn.fm/t3k6S). The company recently acquired a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. In addition, the company has announced the creation of a wholly owned subsidiary — Kaival Labs — that will own the patent and develop associated products.

“The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel. “The exclusivity is that the patents allow us to control the specific ratios of each isomer in the final synthetic nicotine molecule we produce for cessation products. We can now create completely unique products for smoking cessation and nicotine addiction therapy that remain effective and satisfying for the user, but are free from nicotine’s addictive traits.

“Kaival Labs will own the patented science to create a pure, yet nonaddictive synthetic nicotine for the development and production of smoking cessation and nicotine replacement therapy products,” Patel continued. “Tobacco-Free Nicotine (‘TFN’) is a certified clean, pure, non-tobacco-derived synthetic nicotine, and a key ingredient in numerous products like nicotine patches, lozenges, gums, vape sticks, e-liquids and more.”

Efforts to help smokers who are seeking to quit — including products such as chewing gum, inhalers, lozenges, patches, sprays and sublingual tablets, and therapies such as nicotine replacement therapy (“NRT”), non-NRT therapy and e-cigarettes — are not new. However, until now, they were fairly ineffective. A National Health Information Survey reports that while 34.2 million U.S. adults smoke, an estimated 70% of them want to quit — and 55% of them have tried to kick the habit in the last year (https://ibn.fm/cgBHr). Unfortunately, the success rate for quitting is under 10% because nicotine is so addictive.

Because Kaival Brands’ newly acquired patent provides the ability to control levels of both the S-isomers and the R-isomers in the nicotine molecule, the company intends to formulate and offer patented, true step-down products that reduce nicotine addiction levels without decreasing the benefits.

“Smokers and tobacco users worldwide are looking for an answer and a real solution to their nicotine addiction problems,” Patel said. “Imagine patent-protected products, either approved pharmaceutically or made available over the counter, that offered a way to truly ease a user off their addictive cravings for nicotine without losing any of their accustomed benefits along the way. We are excited to develop these innovative patents and bring effective, enjoyable smoking cessation products to market, helping all nicotine users lead healthier and higher-quality lives.”

Kaival Brands is a fast-growing company focused on generating wealth by seeking to incubate innovative products into mature and dominant brands in their respective markets. Our vision is to develop internally, acquire or own, and exclusively distribute these profitable brands with recognizable innovation and superior quality.

For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

• SGTM awarded contract for tree services in Lake County, Florida through subsidiary Central Florida Arborcare
• SGTM subsidiary Mulch Manufacturing recently awarded two additional packaging contracts
• Subsidiary ArborPro of Mississippi Inc. awarded contract for Hurricane Laura recovery efforts
• Q2 results include $12.3 million revenue and $3.4 million gross profit

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, recently announced that Central Florida Arborcare, its wholly-owned subsidiary, was awarded a one-year contract to supply tree trimming and related services to the county, renewable for an additional four times over a one-year period. Along with tree services, SGTM provides debris hauling and waste removal as part of its overall operations that transform organic waste into environmentally-friendly products such as mulch and playground surfacing material.

“Getting awarded this contract is allowing us to stay on point with our growth, building relationships with municipalities and governments,” said SGTM CEO and Director Tony Raynor (https://ibn.fm/4RVW1). “We are very fortunate to be an essential business that has proven to stand strong through these economically hard times.”

Despite the economic hardships currently being experienced by businesses across the country, SGTM has grown. The new contract comes shortly after subsidiary Mulch Manufacturing Inc. was awarded a 2021 mulch packaging contract renewal from Menards Inc., the third-largest home improvement chain in the U.S. with 350 stores in operation across 15 states. Also in the pipeline for Mulch Manufacturing is another contract with Old Castle Lawn & Garden to supply large home improvement chains in the Midwest. ‘

SGTM takes its role as a caretaker of the environment seriously by providing remediation efforts in the wake of hurricanes and other natural disasters such as Hurricane Laura. Through its strategic partner, ArborPro of Mississippi Inc., SGTM contributed to recovery efforts in Louisiana by providing services that diverted damaged trees and other vegetation from landfills. The busy hurricane season is expected to contribute significantly to the company’s bottom line this quarter, building upon already impressive Q2 results that included over $12.3 million in revenue and $3.4 million in gross profit (https://ibn.fm/BjJa1).

SGTM plans to expand operations through a combination of organic growth, national partnerships and strategic acquisitions. The company’s strong commitment to environmental sustainability was a primary factor behind the recent name and ticker change from National Storm Recovery Inc. (OTC: NSRI) to Sustainable Green Team, Ltd. (OTC: SGTM). Along with driving forward its mission, the company also aims to maximize value to shareholders seeking ethical investment opportunities in businesses with significant growth potential that can withstand increasingly challenging economic conditions.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/Ss6pO.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Pure Extract Technologies has been awarded Standard Processing License by Health Canada
• The license will enable the Company to produce, sell cannabis & hemp products to other Licenced Producers in its purpose-built facility located near Whistler, Canada
• Canada’s ability to export worldwide coupled with Company’s EU-GMP compliant facility makes Pure Extracts a natural partner for companies involved within international distribution

Pure Extract Technologies, a privately held British Columbia-domiciled plant extraction company, announced that it had been awarded a Standard Processing Licence by Health Canada under the Cannabis Act, following an extensive and meticulous five-month application and vetting process (https://ibn.fm/xElDa).

Pure Extracts achieved this licensing milestone in spite of the operational hurdles and constraints posed by the ongoing COVID-19 pandemic and has reiterated its confidence that its operational plan, coupled with the Company’s intense focus on employee safety, will allow for normal business practices to be conducted in a safe and efficient manner.

Furthermore, following the award of the Health Canada license, Pure Extracts will now proceed with application to Health Canada for a Natural Health Products Site Licence at its purpose-built extraction facility while adhering to EU Good Manufacturing Practices (“GMP”), which in turn will help ensure that its full spectrum oil (“FSO”) will be extracted to the highest possible quality.

“We are thrilled to be commencing production in our new, EU-GMP compliant, purpose-built facility and are confident that our state-of-the-art extraction and processing equipment will produce the highest-quality cannabis and hemp-derived oil available on the market,” stated Pure Extract Technologies founder and COO Doug Benville following the Health Canada license approval.

With consumer demand for edibles and infused beverages continuing to accelerate, Canadian cultivators have responded to the growth in demand by increasing the quantity of outdoor-grown biomass, which will be readily available for extraction this fall. Pure Extracts in turn has reacted to the forthcoming increase in demand by increasing its workforce, expecting to expand to 14-16 individuals by the end of 2020.

“Pure Extracts plans to position itself as an extraction industry leader in terms of its Full Spectrum Oil FSO quality,” notes CEO Ben Nikolaevsky. “We can’t wait to show our LP partners the incredible quality extracted oil that we can produce, be it for medicinal or recreational usage. Our standards are high, as you would expect from an EU-GMP compliant producer with an exceptionally experienced team. The dedication and determination our team displayed over the last two years has been exemplary.”

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extract Technologies are available in the company’s newsroom at http://ibn.fm/Pure

• Deloitte published report earlier this year looking into growth trends driving the global TMT industry
• Study found that consumers have embraced online streaming platforms in 2020, with average customer subscribing to three streaming platforms
• The Movie Studio has sought to capitalize on sector’s growth through launch of its own streaming platform as well as through purchase of content aggregator, BINGE Networks LLC
• Deloitte ultimately expects online streaming sector to consolidate, with only handful of platforms taking lion’s share of market

As the world progresses through what can only be described as a wildly tumultuous year, it is evident that trends, such as the avid use of online streaming platforms, have emerged – a movement which independent, Florida-based film studio The Movie Studio (OTC: MVES) has sought to capitalize upon through the launch of its own eponymous online streaming platform.

With subscriber numbers for online streaming platforms more than doubling on a year on year basis, global consultancy firm Deloitte set out to delve deeper into the drivers underpinning the sector’s growth, publishing an extensive report setting forth the company’s findings on the current state of the global technology, media and telecommunications industry (https://ibn.fm/Lduh6).

In a recent survey carried out by Deloitte, a larger number of respondents indicated that they had at least one streaming video subscription (69 percent) relative to those who still possessed a traditional paid television subscription (65 percent) for the first time on record (https://ibn.fm/mN5s6). In response to an explosion in the number of online streaming platforms – the past 24 months has seen the launch of Disney+, Peacock, ViacomCBS and HBO Now amongst various others – studios have responded by withdrawing content rights from third-party streaming platforms in a bid to secure original content for their own platforms.

The move to de-aggregate media content in turn has led consumers to subscribe to multiple platforms, with Deloitte’s Digital Media Trends survey finding that consumers had subscriptions to an average of three streaming video services—a number which has remained steady over the past two years. In response to its findings, Deloitte concluded that streaming services owning the broadest content libraries would likely own the inside track to success, a strategy which has been evidenced by the likes of Amazon and Roku, both of which has attempted to bundle their media content offerings with gaming and music content in an attempt to entice subscribers to their platforms.

The Movie Studio has responded to the surge in competition within the online streaming video platform sector through an ambitious original content creation program, one that has seen the company produce and distribute major motion pictures such as ‘Exposure’, ‘Bad Actress’ and ‘Dancing on the Edge’ in recent times. Separately and in addition to its own content generation, MVES announced the acquisition of BINGE Networks, LLC earlier this year; in contrast to stand-alone streaming platforms, BINGE Networks operates as a distribution agent, providing over 100 individual OTT platforms, including the likes of Roku TV, Apple TV and Amazon with access to its content library of over 15,000 videos and 300 indie films (https://ibn.fm/t7Fdt).

Within its report, Deloitte revealed that it ultimately expected the online video streaming platform business to consolidate into a handful of businesses possessing the most extensive content libraries, with consumers selecting a handful of “must have” subscriptions. Meanwhile, those media companies boasting large libraries which did not make the cut could potentially look to launch their own ad-supported streaming services (in a bid to attract non-subscribers) or, in its stead, join an ad-supported aggregator.

Boasting its own subscription-based streaming platform as well as that gained through its acquisition of BINGE Networks, which operates as a content aggregator in its own right, The Movie Studio has taken great strides toward strengthening its hold on a sector which is expected to witness a wave of consolidation in coming years; more critically perhaps, it has also laid the groundwork needed to capitalize on the stunning growth trends within a sector set to grow at a CAGR of 20.4% over the coming seven years (https://ibn.fm/VhfG0).

For more information, visit the company’s website at www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

• Pac Roots Cannabis Corp. dedicated to supplying higher-quality cannabis product
• PACR enters into strategic licensing agreement with Phenome One Corp, providing access to 350 meticulously-designed cultivars
• Company has also employed number of proprietary cultivation techniques to ensure quality of end products, which has contributed to PACR’s stellar industry reputation

Since completing its RTO and being listed on the CSE in May of 2020, Pac Roots Cannabis Corp. (CSE: PACR) has established a strong reputation within the field of cannabis and hemp cultivation, leveraging upon the exceptional genetics of its specialized cultivars as well as an innovative proprietary cultivation technique to ensure the production of extremely high-quality strains. The company’s relentless focus on quality and cutting-edge agricultural methodology has earned it a growing reputation within the global legal cannabis industry—a burgeoning consumer sector expected to surge to an annual value of over $90 billion by 2027, according to a recent study carried out by Data Bridge Market Research (https://ibn.fm/oyEQU).

The enactment of a variety of new laws providing medical patients and recreational consumers with legal access to cannabis has led to a surge in demand for the plant, a need which has grown in-line with the explosive rise in retail demand for marijuana, edibles, and concentrate-based products. With the North American marijuana industry set to grow at a CAGR of 20% over the coming decade, cannabis cultivators have been increasingly hard-pressed to balance the need to ensure bountiful harvests while adhering to stringent quality criteria.

Pac Roots Cannabis Corp., however, has taken multiple measures to ensure the quality of its product. Through a strategic licensing agreement with Phenome One Corp (https://ibn.fm/oxdJL), Pac Roots has gained access to one of Canada’s largest live, genetic cannabis libraries with lab and field-tested, selectively bred seedlings which the company has employed to grow, breed and clone their own unique brands. The partnership has enabled Pac Roots to offer customers a remarkable portfolio of over 350 meticulously-designed cultivars, ranging from CBD-dominant plants with rare terpene profiles to plants with over 30% THC-content as well as West Coast outdoor, botrytis-resistant cultivars.

Through this alliance with Phenome One, Pac Roots has been able to both deliver rich THC and CBD cultivars with unique terpene profiles while simultaneously delivering upon industry-leading grams per watt (“GPW”) yields.

In addition to the company’s meticulous focus on high-quality cultivars, Pac Roots places great emphasis on optimizing the cultivation process by employing a series of unique and proprietary methods. Cannabis plants require varying levels of specific nutrients and soil additives at different stages of growth. These needs can change, depending on whether the plant is still in a vegetative growth phase or nearing its flowering stage.

Pac Roots has sought to address these requirements by custom-formulating nutrients from raw salts, enabling them to cater to the individual requirements of each specific cultivar. In contrast to most commercial growers currently employing commercially available additives, Pac Root’s meticulous focus on customizing the nutrients of each specific cultivar has allowed the company to maximize the CBD and THC profiles of each of its plants – ultimately translating into a higher-quality end product for the retail customers.

Another key issue that has constantly befallen cannabis cultivators is the potential for pests and disease factors, which, if left unchecked, could often have a devastating impact on biomass production yields. Pac Roots addresses these concerns through a two-fold approach, namely by picking the right soil or terroir in which to plant as well as by employing row compaction and specialized mowing techniques, allowing the company’s highly trained workforce to eliminate any potential sources of plant contamination at an early stage.

“It has been a busy for months since listing on the CSE in early May 2020,” said Pac Roots CEO Patrick Elliott. “We are proud to have a healthy crop and remain bullish on delivering a premium, high-yielding product to our customer.”

For more information, visit the company’s website at www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• SRAX moving BIGtoken to separate publicly-traded company through definitive share exchange with Force Protection Video Equipment Corp
• BIGtoken compensates over 16 million users for data which marketers access for fee
• Malcolm CasSelle appointed CEO of BIGtoken following tenure on SRAX’s board of directors
• BIGtoken spinoff allows SRAX to focus on rapid growth of Sequire platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, recently announced that BIGtoken, its proprietary platform that empowers Internet users to control and profit from their data, will become a separate publicly-traded company with Malcolm CasSelle as CEO. Spinning off the platform as a separate company is expected to benefit SRAX with potential upsides while reducing costs, enabling the company to focus on Sequire, its highly successful SaaS data analytics platform geared towards the investment industry.

Subject to certain closing conditions, the definitive share exchange agreement between SRAX and Force Protection Video Equipment Corp (NASDAQ: FPVD) is expected to exchange all of the outstanding equity of BIGtoken for 88.9% of the issued and outstanding shares of FPVD. SRAX’s founder and CEO Christopher Miglino will serve as chairman of the new entity and SRAX board member Malcolm CasSelle has been appointed as CEO.

“BIGtoken has experienced wide adoption from some of the largest marketers in the world and is ready to be on its own. This move will allow SRAX to stay laser focused on the rapid growth of the Sequire platform,” said Miglino in recent statements (https://ibn.fm/qToVO). “Our focus is to get SRAX to profitability, and this move, combined with our significant growth in Sequire, gets us much closer.”

CasSelle brings an extensive range of expertise to BIGtoken, comprised of over 20 years of leadership in several digital media startups, including SVP & GM roles at SeaChange International, a tenure as president at Tribune Publishing, CEO of Timeline Labs, and GM of Groupon’s joint venture with Tencent in China. His seven years on SRAX’s board of directors make him a powerful addition to the executive suite, stemming from experience that spans BIGtoken’s inception straight through to its present-day success.

“I’m thrilled to join BIGtoken as CEO. I’m deeply committed to BIGtoken’s mission and values and believe the company is in a great position to quickly grow its userbase and consequently expand its roster of advertisers,” noted CasSelle (https://ibn.fm/GpdcJ). “Our work ahead is promising. BIGtoken is already working with large brands and agencies and we look forward to helping more brands find and engage their target audiences with our platform.”

The BIGtoken platform empowers brands to unlock the power of data by giving them the ability to target and access specific niche groups across 25,000 unique market segments. Over 16 million users provide that data through compensation agreements that reward them with cash or gift cards when they opt in to give access to their data.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Projections for U.S. retail sales of medical, recreational cannabis on pace to reach $15 billion by end of 2020
• SGMD seeing consistent growth in numbers, supporting expert predictions
• CEO reports “increase in gross margins while demonstrating another breakout month-over-month performance on both the top and bottom line”

Even with the global COVID-19 pandemic causing a speed bump, projections for the retail sales of medical and recreational cannabis in the United states are on pace to reach $15 billion by the end of 2020 (https://ibn.fm/tqh6O). Those numbers, which are an increase of approximately 40% over 2019 sales figures, may not surprise Sugarmade (OTC: SGMD), which has consistently reported record numbers as it builds operations in the California cannabis space.

“Total U.S. sales could rise as high as $37 billion by 2024, according to exclusive projections from the latest Factbook, which was released Monday at MJBizConNEXT Direct,” reported a recent Marijuana Business Daily article. Despite the “huge curveball” that the coronavirus pandemic, threw at projections, the article went on to note that “spending on adult-use cannabis in markets that aren’t tourist-driven has increased, as have sales in nearly every domestic MMJ market.”

The report concluded that despite short-term uncertainty, the long-term potential of the cannabis industry remains intact. “Sharp sales increases in recently launched medical marijuana programs — as well as continued gains in adult-use markets — are expected to fuel much of the industry’s growth over the coming years.”

Recent financial reports from Sugarmade seem to confirm these projects. In its most recent numbers report, the company noted that gross sales for its BudCars Cannabis Delivery Service totaled $662,836, representing 32% month-over-month sales growth compared to June 2020 sales (https://ibn.fm/wuuTf). In addition, average daily gross sales increased 32% month-over month to $22,095, with total customer tickets increasing 33% month over month. In short, SGMD’s calendar Q3 is on pace to potentially more than double its calendar Q2 total BudCars sales.

“Last month featured strong growth in basically every major metric once again for our BudCars segment. We saw an increase in gross margins while demonstrating another breakout month-over-month performance on both the top and bottom line,” said Sugarmade CEO Jimmy Chan. “Note that April was our first full month operating BudCars. In July we more than doubled the sales and gross profits booked in April. That pace of growth suggests another potential doubling by October on a per-location basis. And we will be operating additional locations by then, which will serve to compound that growth.”

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes CarryOutsupplies.com and SugarRush(TM).

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field
• PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil (e.g., CBD, Vitamins) to be more readily absorbed by human biology
• Development of th proprietary new instrument – the BaroShear K45-has been proceeding well since the Company received orders for all of its planned initial build of 12 units
• Pressure BioSciences reported achieving a critical milestone in the production of the BaroDShear K45 units on Oct. 6 with the lock-in of final design specifications for the commercial model and commencement of building the initial “Alpha” model
• The Company states that once the Alpha model is built, tested and approved, an additional 14 ready-for-sale systems will be built (12 for sale) in time to fulfill plans for shipping the contracted BaroShear K45 Nanoemulsification Systems during early 2021
• The sale of the first dozen BaroShear K45 units is expected to generate up to $3 million for Pressure BioSciences’ revenue stream in just the first half of 2021
• Pressure BioSciences expects that the installation of the initial 12 commercial units will propel the sale of significantly more BaroShear K45 units during the second half of 2021 and thereafter

Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has achieved another milestone as it nears the initial production of commercial pressure-inducing technology systems expected to revolutionize a wide variety of industries through the nanoemulsification process.

Pressure BioSciences’ proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils so that they become more easily absorbed and effective in the water-based biology of human bodies.

During the weeks before news about the novel COVID-19 virus’ global spread to pandemic levels seized the reins of media coverage, Pressure BioSciences announced it was launching its UST Demonstration Laboratory as a place to showcase the technology’s potential to process cannabidiol (“CBD”) oil into true, high-quality, water-soluble nanoemulsions (https://ibn.fm/uFDuU). Several months later, PBIO announced it had reached sold-out status for its initial rollout of 12 planned BaroShear K45 systems.

On Oct. 6, the Company announced the lock-in of final design specifications for the BaroShear K45’s commercial production model, which immediately launched work on construction of the initial K45 “Alpha” unit. Once the Alpha unit is built, tested and approved, the Company will build an additional 14 units, 12 of which are earmarked as ready-for-sale systems in time for the Company to fulfill plans for shipping them during early 2021 (https://ibn.fm/x783G).

“Our commercialization plan for the BaroShear K45 system is initially focused on the rapidly growing hemp-derived CBD market, which is projected to reach $20 billion by 2020,” Director of Marketing and Sales Kenneth F. Micciche stated in the announcement. “We plan to install these (12 BaroShear K45 nanoemulsification) systems during the first half of 2021, which we believe will generate up to $3 million in revenue. Once these initial units are installed and in commercial use, we believe they will propel the close of multiple sales of additional BaroShear K45 systems during the latter half of 2021 and thereafter.”

The Company signed a binding letter of intent to merge with Cannaworx, Inc. (USA) and its portfolio of products and IP in April, which is expected to close shortly (https://ibn.fm/iqrRn). This merger is also expected to bring two additional companies into the new company, which will be known as Availa Bio. These companies are cosmetics industry SkinScience Labs, Inc. (owner of Dr. Denese Skin Care Products, a QVC regular) and cannabis industry Five Leaf Labs, as these additional firms are expected to be signed by Cannaworx under its brand stable once the negotiations are complete.

The UST platform not only processes oils into nanoemulsions that make the oil-based solutions more readily soluble in water, it promotes extended shelf life and/or room temperature stability for low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. It is also expected to improve the fine silky appearance and texture of cosmetic industry products.

Patents have been issued on UST technology in China; PBIO believes that patents should begin to be issued in the United States and in many other parts of the world soon.

For more information, visit the company’s website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• Sustainable Green Team Ltd. announced series of new partnerships for its subsidiaries
• National Storm Recovery stated that it had entered into an alliance with Tree Leads Today to source contracts outside of their traditional geographical coverage area
• Mulch Manufacturing Inc., SGTM’s wholly-owned mulch producing subsidiary, announced that it had renewed its agreement to supply mulch products to home-improvement chain, Menards Inc.

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has recently updated the market on the significant progress achieved by its subsidiaries, as both National Storm Recovery LLC and Mulch Manufacturing Inc. announced new partnership agreements.

National Storm Recovery LLC announced that it had formed a strategic alliance with Tree Leads Today to expand their national partnerships in a bid to obtain contracts currently outside of their geographic sphere of activity (https://ibn.fm/sCGQo). The strategic alliance was formed when National Storm Recovery deployed its teams to assess damages from Hurricane Laura, with Tree Leads Today helping the Company partner with ArborPro of Mississippi Inc. on a recovery contract awarded for recovery work carried out in the city of Sulphur, Louisiana.

Tree Leads Today is a privately held company with a nationwide footprint. The company is focused on providing tree companies with leads on tree care projects and services. The process of generating leads is done strategically so that leads are as close to one another as possible in order to maximize productivity for TLT’s tree care partners when they are giving estimates and completing contracted jobs.

“We are honored to be partnering with such an innovative and environmentally conscious organization as Sustainable Green Team,” commented Tree Leads Today CEO Don Dowd. “Tree Leads Today believes in a pay-for-performance model. We believe in our offerings so much that we take all of the risks and only expect you to pay if we deliver.”

“This strategic alliance will amplify our national partnerships and, most importantly, increase recovery contracts far beyond our reach through our Central Florida Arbor Care subsidiary,” said SGTM CEO and director Tony Raynor. “Our new strategic alliance with Tree Leads Today removes all of our limits, opening many new opportunities for our brand, team and shareholders.”

Simultaneously, SGTM has also announced that its wholly owned subsidiary, Mulch Manufacturing Inc. (“MMI”) has been awarded a 2021 mulch packaging contract renewal from Menards Inc.

Menards operates the third-largest home improvement chain in the U.S., managing 350 stores spread across 15 states. Mulch Manufacturing Inc. has been supplying Menards with mulch products dating back to 2010, with the current contract renewal dictating that Menards would increase the number of its stores carrying MMI’s mulch products by 25% over the course of the next calendar year.

SGTM’s CEO and Director Tony Raynor commented in relation to the news, “Menards mulch packaging contract renewal brings me great pride on team and the direction we’re headed. I’m a firm believer that you’re only as strong as your team, and SGTM’s achievements and trajectory validates it.”

To learn more, view the company’s investor presentation at https://ibn.fm/HOGkq

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• This is the company’s first line of premium products to be introduced into the market, and will be primarily distributed in countries with the highest demand for functional and medicinal mushroom superfood products – the U.S., Canada, and Japan
• The company is working with select retailers for an imminent strategic launch date.
• The company is set to launch a premium and user-friendly shopping experience through it’s e-commerce website
• The functional mushroom industry’s current demand is forecasted to $34 billion by 2024, with a global market expected to reach $50 billion by 2025
• The market has no clear brand leader at the moment, but Rritual is intent to capitalize on its innovative product line to take this position
• Company’s current marketing plan can help achieve this goal by simplifying operations and promoting business growth with a reduced time to market

Rritual Mushrooms is emerging as a premium, leading brand in the functional food and mushroom market following the launch of its innovative suite of premium functional mushroom and adaptogenic elixirs this fall. “The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research. Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects,” said Dr. Mike Hart, President of Rritual, who also oversaw the development of the new line of products (https://ibn.fm/hze7A).

The premium suite of products consists of three different formulas made from the company’s proprietary blend of adaptogenic herbs and organic mushrooms: Reishi Relax, Chaga Immune, and Lion’s Mane Focus.

Developed for stress support, balancing mood, and facilitating restful sleep, the Reishi Relax blend is infused with cacao, ashwagandha root, and cinnamon to provide optimal wellness. Chaga Immune, also featuring Atragulus and the proprietary immune blend created by Rritual, works to enhance immune health and strengthen the body’s stress defenses. Lion’s Mane Focus was developed for cognitive health and enhanced memory and creativity, offering a mental boost as a result of its composition that includes Rhodiola root and Ayurvedic herbs like Bacopa.

Upon release, these premium products will be available through the Rritual website and the Rritual Amazon store. Each elixir will come in a 14 stick pack or 250-gram tub. A combo pack will also be available featuring all three elixir sticks in a 14 count pack.

Rritual’s premium products are the first premium brands to hit the functional mushroom market, a fast-growing sector where demand is growing and is forecasted to rise to $34 billion by 2024. As of right now, there is no clear leader in the industry, but Rritual may take this position with the release of its new products. Globally the market for functional mushrooms is expected to reach $50 billion by 2025. The current marketing structure of Rritual shows the plan to deliver its products to the United States, Canada, and Japan, countries with the highest demand for functional and medicinal mushroom superfood products.

Since its launch in 2019, Rritual’s sole purpose has been to help every person meet the demands within their life with style and ease through mushroom adaptogens. All products are plant-based and vegan, without the use of artificial sweeteners or fillers. Each product produced by Rritual is made with the principle of creating a product with limited, yet purposeful organic ingredients.

Rritual is currently working on two different marketing strategies – e-commerce and brick and mortar. Each of these strategies will be completed in two phases. The fall release is stage one of the e-commerce strategy currently underway. The second stage of the e-commerce strategy is to use team connections to create a direct-to-consumer experience using mediums such as Costco, CVS Pharmacy, Walmart, and Vitacost.

In stage one, the brick and mortar strategy will see the launch of the premium products in four non-competing store chains that have a shared best practice agreement. The stage two plan expands upon the first, but expansion will include 11 more retailers selling the product in a set number of their stores.

The “low hanging fruit” strategy and turnkey, global services market, will significantly lower the time it will take for Rritual’s products to find their way into a leading position within the industry. These strategies also simplify operations and support the company’s scaling efforts, helping it enhance its visibility on a market waiting for a leader.

For more information, visit the company’s website at www.WeAreRritual.com. 

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual